Wall Street Analysts Predict a 25.99% Upside in Verona Pharma (VRNA): Here's What You Should Know

Verona Pharma PLC American Depositary Share (VRNA) closed the last trading session at $90.48, gaining 6.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $114 indicates a 26% upside potential.The average comprises 10 short-term price targets ranging from a low of $90.00 to a high of $160.00, with a standard deviation of $23.98. While the lowest estimate indicates a decline of 0.5% ...